{"id":"W2205041904","doi":"10.1007/s10637-015-0316-5","title":"Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers","year":2015,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Vandetanib; Capecitabine; Gemcitabine; Medicine; Internal medicine; Pancreatic cancer; Gastroenterology; Tyrosine-kinase inhibitor; Oncology; Neutropenia; Cancer; Chemotherapy; Sorafenib; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005093284,0.000179016,0.0006619054,0.0003436582,0.00002154365,0.000008264678,0.00004780054,0.00006797443,0.00000816285],"category_scores_gemma":[0.0002109772,0.0001275018,0.00000809977,0.0004909104,0.0004182578,0.0003443208,0.00001752731,0.0002001201,3.058786e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002947973,"about_ca_system_score_gemma":0.001570657,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001606083,"about_ca_topic_score_gemma":0.001697468,"domain_scores_codex":[0.9983152,0.0001235876,0.0004310617,0.0003008541,0.0005730729,0.0002562913],"domain_scores_gemma":[0.9989746,0.0001737016,0.0001511869,0.0001498219,0.0001741016,0.0003765599],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04636498,0.001028456,0.9495132,0.00005546386,0.00003885897,0.00002136555,0.001901645,0.00009984049,0.00005875362,0.0001254548,0.0000115028,0.0007805045],"study_design_scores_gemma":[0.2275731,0.009303651,0.7593366,0.0004339152,0.00005979997,0.00001255698,0.0006857053,0.001705127,0.00008337068,0.0006713694,0.00000299247,0.0001318033],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975439,0.00008129441,0.00001745669,0.0003479073,0.0000150543,0.001732028,0.000009155227,0.00000985914,0.0002433813],"genre_scores_gemma":[0.9960669,0.00002192181,0.003408322,0.00010312,0.00002616944,0.0001310025,0.0001564496,0.00001894479,0.00006717446],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1901766,"threshold_uncertainty_score":0.5199371,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02157323949200639,"score_gpt":0.3128161131465707,"score_spread":0.2912428736545642,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}